{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T14:51:56Z","timestamp":1753887116223,"version":"3.41.2"},"reference-count":26,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","content-domain":{"domain":["www.ahajournals.org"],"crossmark-restriction":true},"short-container-title":["JAHA"],"published-print":{"date-parts":[[2020,6,16]]},"abstract":"<jats:sec xml:lang=\"en\">\n            <jats:title>Background<\/jats:title>\n            <jats:p xml:lang=\"en\">\n              There are conflicting data regarding the benefit of primary prevention implantable cardioverter\u2010defibrillators (\n              <jats:styled-content style=\"fixed-case\">ICD<\/jats:styled-content>\n              s) in patients with diabetes mellitus and heart failure (HF) with reduced ejection fraction. We aimed to assess the comparative effectiveness of\n              <jats:styled-content style=\"fixed-case\">ICD<\/jats:styled-content>\n              placement in patients with diabetes mellitus and HF with reduced ejection fraction.\n            <\/jats:p>\n          <\/jats:sec>\n          <jats:sec xml:lang=\"en\">\n            <jats:title>Methods and Results<\/jats:title>\n            <jats:p xml:lang=\"en\">\n              Data were obtained from the Get With the Guidelines\u2013Health Failure registry, linked with claims from the Centers for Medicare &amp; Medicaid Services. We used a Cox proportional hazards model censored at 5\u00a0years with propensity score matching. Of the 17\u00a0186 patients with HF with reduced ejection fraction from the Centers for Medicare &amp; Medicaid Services claims database (6540 with diabetes mellitus; 38%), 1677 (646 with diabetes mellitus; 39%) received an\n              <jats:styled-content style=\"fixed-case\">ICD<\/jats:styled-content>\n              during their index HF hospitalization or were prescribed an\n              <jats:styled-content style=\"fixed-case\">ICD<\/jats:styled-content>\n              at discharge. Patients with diabetes mellitus and an\n              <jats:styled-content style=\"fixed-case\">ICD<\/jats:styled-content>\n              (n=646), as compared with those without an\n              <jats:styled-content style=\"fixed-case\">ICD<\/jats:styled-content>\n              (n=1031), were more likely to be younger (74 versus 78\u00a0years of age) and have coronary artery disease (68% versus 60%). After propensity matching,\n              <jats:styled-content style=\"fixed-case\">ICD<\/jats:styled-content>\n              use among patients with diabetes mellitus, as compared with those without an\n              <jats:styled-content style=\"fixed-case\">ICD<\/jats:styled-content>\n              , was associated with a reduced risk of all\u2010cause mortality at 5 years after\n              <jats:styled-content style=\"fixed-case\">HF<\/jats:styled-content>\n              discharge (54% versus 59%; multivariable hazard ratio, 0.73; 95%\n              <jats:styled-content style=\"fixed-case\">CI<\/jats:styled-content>\n              , 0.64\u20130.82;\n              <jats:italic>P<\/jats:italic>\n              &lt;0.0001). Ischemic heart disease did not modify the association between\n              <jats:styled-content style=\"fixed-case\">ICD<\/jats:styled-content>\n              use and all\u2010cause mortality (\n              <jats:italic>P<\/jats:italic>\n              =0.95 for interaction). Similar results were seen in patients without diabetes mellitus.\n            <\/jats:p>\n          <\/jats:sec>\n          <jats:sec xml:lang=\"en\">\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p xml:lang=\"en\">\n              Primary prevention\n              <jats:styled-content style=\"fixed-case\">ICD<\/jats:styled-content>\n              use among older patients with HF with reduced ejection fraction and diabetes mellitus was associated with a reduced risk of all\u2010cause mortality. Our analysis supports current guideline recommendations for implantation of primary prevention\n              <jats:styled-content style=\"fixed-case\">ICD<\/jats:styled-content>\n              s among older patients with diabetes mellitus and HF with reduced ejection fraction.\n            <\/jats:p>\n          <\/jats:sec>","DOI":"10.1161\/jaha.119.012405","type":"journal-article","created":{"date-parts":[[2020,5,30]],"date-time":"2020-05-30T09:10:58Z","timestamp":1590829858000},"update-policy":"https:\/\/doi.org\/10.1161\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":1,"title":["Comparative Effectiveness of Primary Prevention Implantable Cardioverter\u2010Defibrillators in Older Heart Failure Patients With Diabetes Mellitus"],"prefix":"10.1161","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2346-8330","authenticated-orcid":false,"given":"Abhinav","family":"Sharma","sequence":"first","affiliation":[{"name":"Duke Clinical Research Institute Duke University School of Medicine Durham NC"},{"name":"McGill University Health Centre Montreal Quebec Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingjing","family":"Wu","sequence":"additional","affiliation":[{"name":"Duke Clinical Research Institute Duke University School of Medicine Durham NC"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haolin","family":"Xu","sequence":"additional","affiliation":[{"name":"Duke Clinical Research Institute Duke University School of Medicine Durham NC"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adrian","family":"Hernandez","sequence":"additional","affiliation":[{"name":"Duke Clinical Research Institute Duke University School of Medicine Durham NC"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G. Michael","family":"Felker","sequence":"additional","affiliation":[{"name":"Duke Clinical Research Institute Duke University School of Medicine Durham NC"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sana","family":"Al\u2010Khatib","sequence":"additional","affiliation":[{"name":"Duke Clinical Research Institute Duke University School of Medicine Durham NC"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer","family":"Green","sequence":"additional","affiliation":[{"name":"Duke Clinical Research Institute Duke University School of Medicine Durham NC"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roland","family":"Matsouaka","sequence":"additional","affiliation":[{"name":"Duke Clinical Research Institute Duke University School of Medicine Durham NC"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregg C.","family":"Fonarow","sequence":"additional","affiliation":[{"name":"Ahmanson\u2013UCLA Cardiomyopathy Center Los Angeles CA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jagmeet P.","family":"Singh","sequence":"additional","affiliation":[{"name":"Massachusetts General Hospital Boston MA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul A.","family":"Heidenreich","sequence":"additional","affiliation":[{"name":"Veterans Affairs Palo Alto Health Care System Palo Alto CA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Justin A.","family":"Ezekowitz","sequence":"additional","affiliation":[{"name":"Faculty of Medicine and Dentistry, Canadian VIGOUR Center University of Alberta Edmonton Alberta Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adam","family":"DeVore","sequence":"additional","affiliation":[{"name":"Duke Clinical Research Institute Duke University School of Medicine Durham NC"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"e_1_3_1_2_2","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.117.004646","article-title":"Trends in noncardiovascular comorbidities among patients hospitalized for heart failure","author":"Sharma A","year":"2018","unstructured":"Sharma A, Zhao X, Hammill BG, Hernandez AF, Fonarow GC, Felker GM, Yancy CW, Heidenreich PA, Ezekowitz JA, DeVore AD. Trends in noncardiovascular comorbidities among patients hospitalized for heart failure. Circ Heart Fail. 2018;e004646.","journal-title":"Circ Heart Fail"},{"key":"e_1_3_1_3_2","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehw106"},{"key":"e_1_3_1_4_2","first-page":"E67","article-title":"Heart disease and stroke statistics\u20142018 update: a report from the American Heart Association","author":"Benjamin EJ","year":"2018","unstructured":"Benjamin EJ, Virani SS, Callaway CW, Chamberlain AM, Chang AR, Cheng S, Chiuve SE, Chushman M, Dellin FN, Deo R, et al. Heart disease and stroke statistics\u20142018 update: a report from the American Heart Association. Circulation. 2018;E67\u2013E492.","journal-title":"Circulation"},{"key":"e_1_3_1_5_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.114.014796"},{"key":"e_1_3_1_6_2","doi-asserted-by":"publisher","DOI":"10.2337\/dc17-1091"},{"key":"e_1_3_1_7_2","doi-asserted-by":"publisher","DOI":"10.1002\/ejhf.912"},{"key":"e_1_3_1_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jchf.2018.05.020"},{"key":"e_1_3_1_9_2","doi-asserted-by":"publisher","DOI":"10.1002\/ejhf.1192"},{"key":"e_1_3_1_10_2","first-page":"e210","article-title":"2017 AHA\/ACC\/HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: executive summary","author":"Al\u2010Khatib SM","year":"2018","unstructured":"Al\u2010Khatib SM, Stevenson WG, Ackerman MJ, Bryant WJ, Callands DJ, Curtis AB, Deal BJ, Dickfeld T, Field ME, Fonarrow GC, et al. 2017 AHA\/ACC\/HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: executive summary. Circulation. 2018;e210\u2013e271.","journal-title":"Circulation"},{"key":"e_1_3_1_11_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0b013e31829e8807"},{"key":"e_1_3_1_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2017.03.568"},{"key":"e_1_3_1_13_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.117.028829"},{"key":"e_1_3_1_14_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1608029"},{"key":"e_1_3_1_15_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.297.1.61"},{"key":"e_1_3_1_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2009.04.002"},{"key":"e_1_3_1_17_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCOUTCOMES.109.854877"},{"key":"e_1_3_1_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jchf.2013.01.008"},{"key":"e_1_3_1_19_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa041489"},{"key":"e_1_3_1_20_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0901889"},{"key":"e_1_3_1_21_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa043399"},{"key":"e_1_3_1_22_2","article-title":"Comparative effectiveness of implantable cardioverter defibrillators for primary prevention in women","author":"Zeitler EP","year":"2016","unstructured":"Zeitler EP, Hellkamp AS, Schulte PJ, Fonarow GC, Hernandez AF, Peterson ED, Sanders GD, Ynacy CW, Alk\u2010Khatib SM. Comparative effectiveness of implantable cardioverter defibrillators for primary prevention in women. Circ Heart Fail. 2016;e002630.","journal-title":"Circ Heart Fail"},{"key":"e_1_3_1_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2018.03.362"},{"key":"e_1_3_1_24_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10557-017-6729-y"},{"key":"e_1_3_1_25_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1504720"},{"key":"e_1_3_1_26_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1611925"},{"key":"e_1_3_1_27_2","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehv728"}],"container-title":["Journal of the American Heart Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ahajournals.org\/doi\/full\/10.1161\/JAHA.119.012405","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,13]],"date-time":"2024-05-13T11:30:38Z","timestamp":1715599838000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ahajournals.org\/doi\/10.1161\/JAHA.119.012405"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,16]]},"references-count":26,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2020,6,16]]}},"alternative-id":["10.1161\/JAHA.119.012405"],"URL":"https:\/\/doi.org\/10.1161\/jaha.119.012405","relation":{},"ISSN":["2047-9980"],"issn-type":[{"type":"electronic","value":"2047-9980"}],"subject":[],"published":{"date-parts":[[2020,6,16]]},"assertion":[{"value":"2019-03-27","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-12-04","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-05-30","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e012405"}}